Teva Pharmaceutical Industries | TEVA - Operating Profit

Stock Price
10,100.00
Daily Change
-210.00 -2.04%
Monthly
6.89%
Yearly
66.83%
Q2 Forecast
10,239.83

Teva Pharmaceutical Industries reported $758M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Aspen Pharmacare ZAR 3.76B 1.04B Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 888M 13.05B Mar/2026
Guangzhou Baiy CNY 2.26B 2.92B Mar/2026
Jiangsu Hengrui CNY 2.56B 302M Mar/2026
Kalbe Farma IDR 851.77B 208.4B Sep/2025
Richter Gedeon HUF 63.58B 6.08B Sep/2025
Sh Fosun Pharma CNY 817.9M 46.25M Mar/2026
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
Teva Pharmaceutical Industries USD 758M 271M Mar/2026